GlassScriptPhysician profile
Gregory Scott Shaw
NPI 1841820834
$1,349.38
in general payments reported to CMS, 2019-2025
13 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.05 · 2022: $137 · 2023: $226 · 2024: $470 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $309.18 | 2024-2025 | |
| Pfizer INC. | $294.69 | 2023-2025 | |
| Novo Nordisk INC | $196.81 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $131.57 | 2023-2025 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $114.21 | 2023-2025 | Heplisav-B |
| Dexcom, INC. | $74.31 | 2023-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $59.77 | 2021-2025 | Shingrix, Bexsero |
| Sanofi Pasteur INC. | $54.17 | 2023-2024 | |
| Viiv Healthcare Company | $31.02 | 2024 | Apretude |
| Merck Sharp & Dohme LLC | $30.37 | 2025 | Enflonsia, Gardasil 9, Capvaxive |
| Regeneron Healthcare Solutions, INC. | $24.55 | 2025 | Dupixent |
| Phadia US INC. | $16.30 | 2024 | Immunocap |
| Medtronic, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.